ArticleBMC plant biology2026
AMF-mediated samarium tolerance in Avena sativa: insights into primary metabolism, amino acid biosynthesis, and flavonoid accumulation.
Article in BMC plant biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
backgroundSamarium (Sm), a rare earth element increasingly released into the environment through industrial activities and electronic waste, can adversely affect plant growth and metabolism. Although arbuscular mycorrhizal fungi (AMF) are known to enhance plant tolerance to various abiotic stresses, their role in mitigating Sm toxicity and regulating metabolic pathways in oat (Avena sativa L.) remains poorly understood. This study investigated the physiological and metabolic mechanisms underlying AMF-mediated Sm tolerance in oat plants.
methodsA greenhouse pot experiment was conducted using oat plants grown under control conditions or exposed to Sm stress (125 and 250 mg kg⁻¹ soil), with or without Rhizophagus irregularis inoculation. Plant growth, grain yield, photosynthetic performance, nutrient status, Sm accumulation, carbohydrate metabolism, nitrogen-assimilating enzymes, amino acid profiles, organic and fatty acids, and secondary metabolites were analyzed.
resultsSm exposure markedly impaired plant performance, reducing grain yield by up to 60% and decreasing the photosynthetic rate by 43.2-60% compared to the control. Sm stress also disrupted nutrient acquisition and induced substantial metabolic imbalances. AMF inoculation significantly alleviated these adverse effects by reducing Sm accumulation in plant tissues (by 21.7% and 31.5% at the low and high Sm levels, respectively) and increasing grain yield by up to 33.9% compared with non-inoculated stressed plants. AMF enhanced carbohydrate metabolism (increasing glucose content and starch synthase activity) and stimulated nitrogen metabolism by increasing glutamine synthetase and glutamate dehydrogenase activities, leading to greater accumulation of several amino acids. AMF also promoted the accumulation of organic acids, fatty acids, and protective secondary metabolites (phenolics and tocopherols). Effects on phenolics, flavonoids, and antioxidant capacity were treatment-dependent, with AMF generally enhancing these parameters under non-stressed or low-Sm conditions while modulating the stress-induced responses at high Sm concentrations.
conclusionsAMF effectively mitigated Sm-induced toxicity in oat by limiting Sm accumulation, preserving photosynthetic function, enhancing primary metabolism, stimulating amino acid biosynthesis, and promoting protective secondary metabolites. These findings provide new insights into the metabolic basis of AMF-mediated tolerance to rare earth element stress and highlight the potential application of AMF as a sustainable strategy for crop production in contaminated soils.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.